Jane Visvader
Affiliations: | The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia |
Google:
"Jane Visvader"Mean distance: 17.39 (cluster 19)
Children
Sign in to add trainee| Gwyndolen C. Harburg | post-doc | 2007-2009 | Walter and Eliza Hall Institute of Medical Research |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Joyce R, Pascual R, Heitink L, et al. (2024) Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers. Nature Cell Biology |
| Milevskiy MJG, Coughlan HD, Kane SR, et al. (2023) Three-dimensional genome architecture coordinates key regulators of lineage specification in mammary epithelial cells. Cell Genomics. 3: 100424 |
| Sharma S, Chung CY, Uryu S, et al. (2023) Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer. Cell Chemical Biology |
| Wang Z, Hu H, Heitink L, et al. (2023) The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell Death and Differentiation |
| Chen Y, Pal B, Lindeman GJ, et al. (2022) R code and downstream analysis objects for the scRNA-seq atlas of normal and tumorigenic human breast tissue. Scientific Data. 9: 96 |
| Wilson MM, Callens C, Le Gallo M, et al. (2021) An EMT-primary cilium-GLIS2 signaling axis regulates mammogenesis and claudin-low breast tumorigenesis. Science Advances. 7: eabf6063 |
| Pal B, Chen Y, Vaillant F, et al. (2021) A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast. The Embo Journal. e107333 |
| Holliday H, Roden D, Junankar S, et al. (2021) Inhibitor of Differentiation 4 (ID4) represses mammary myoepithelial differentiation via inhibition of HEB. Iscience. 24: 102072 |
| Lalaoui N, Merino D, Giner G, et al. (2020) Targeting triple-negative breast cancers with the Smac-mimetic birinapant. Cell Death and Differentiation |
| Dekkers JF, Whittle JR, Vaillant F, et al. (2019) Modeling breast cancer using CRISPR/Cas9-mediated engineering of human breast organoids. Journal of the National Cancer Institute |